Zhiguo Ding
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhiguo Ding has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Junhui Wang
Thyropathy Hospital, Sun Simiao Hospital, Beijing University of Chinese Medicine, Tongchuan 727000, China
4 shared publications Peijin Li
Department of Thyropathy, Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing, China
3 shared publicationsQian Wang
Department of Endocrinology, The Second People’s Hospital of China Three Gorges University, Yichang, Hubei, China
3 shared publications- Shuo Qi
Dongzhimen Hospital Beijing University of Chinese Medicine Beijing China
3 shared publications - Chen Xiaoheng
Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
2 shared publications Jingwei Zhou
The 1st Ward, Department of Nephrology and Endocrinology, Dongzhimen Hospital, Beijing University of Chinese Medicine
2 shared publications
Latest Publications
- Open Access
- 9 September 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1896060
Research progress on the association between Hashimoto’s thyroiditis and autoimmune encephalitis: a review
Hashimoto’s thyroiditis (HT), which is the most common autoimmune thyroid disease, has, in recent times, been the subject of growing interest because of its possible link with autoimmune encephalitis (AE). This overview comprehensively reviews the epidemiological connections, shared immunopathological mechanisms, common clinical manifestations, diagnostic issues, and treatment methods of HT and AE. By combining the most recent progress in immunology, brain imaging, and clinical studies, we analyze the similarities and differences between HT-associated encephalopathy, commonly identified as Hashimoto’s encephalopathy, and the standard types of AE. Despite these advances, diagnostic and therapeutic challenges remain in patients who show neurological symptoms in the context of HT. The aim of this paper was to enhance the knowledge of clinicians about the connection between these two autoimmune disorders, normalize diagnostic procedures, and update treatment methods in order to achieve better patient results. Furthermore, this paper outlines some of the directions for future work that would help reveal mechanisms and develop clinical management.
- 9 September 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1896060
Open AccessResearch progress on the association between Hashimoto’s thyroiditis and autoimmune encephalitis: a review
Hashimoto’s thyroiditis (HT), which is the most common autoimmune thyroid disease, has, in recent times, been the subject of growing interest because of its possible link with autoimmune encephalitis (AE). This overview comprehensively reviews the epidemiological connections, shared immunopathological mechanisms, common clinical manifestations, diagnostic issues, and treatment methods of HT and AE. By combining the most recent progress in immunology, brain imaging, and clinical studies, we analyze the similarities and differences between HT-associated encephalopathy, commonly identified as Hashimoto’s encephalopathy, and the standard types of AE. Despite these advances, diagnostic and therapeutic challenges remain in patients who show neurological symptoms in the context of HT. The aim of this paper was to enhance the knowledge of clinicians about the connection between these two autoimmune disorders, normalize diagnostic procedures, and update treatment methods in order to achieve better patient results. Furthermore, this paper outlines some of the directions for future work that would help reveal mechanisms and develop clinical management.
- Open Access
- 17 August 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1909257
Endoplasmic reticulum stress in Hashimoto’s thyroiditis: a candidate amplification node linking thyroid-specific vulnerability and immune dysregulation
Hashimoto’s thyroiditis (HT) is the most prevalent autoimmune thyroid disease, characterized by lymphocytic infiltration and destruction of thyroid follicular architecture. Prior research has predominantly focused on aberrant adaptive immune activation, whereas the contribution of the thyroid follicular cell itself to this process remains incompletely elucidated. This narrative review synthesizes evidence implicating endoplasmic reticulum stress (ERS) in HT pathogenesis, stratifying the evidence by its proximity to HT pathology into three tiers: direct evidence, thyroid-cell evidence, and extrapolated evidence. Thyroid follicular cells continuously produce large quantities of structurally complex thyroglobulin, placing the ER under near-saturated folding load even under physiological conditions, thereby conferring an organ-specific vulnerability. Multiple HT-associated factors can activate the unfolded protein response (UPR), mediating thyrocyte apoptosis, suppression of functional genes, and loss of epithelial phenotype in thyroid cell models; individual UPR branches may also regulate the differentiation and function of infiltrating immune cells. Integrating the above evidence, this review proposes a testable positive-feedback perspective in which thyrocyte ERS injury and immune effector amplification may mutually reinforce one another. This perspective comprises six steps, and for each step, the strength of supporting evidence is assessed. Among these, only thyrocyte ERS activation and the macrophage IRE1α pathway have received preliminary direct evidence in HT or experimental autoimmune thyroiditis (EAT); support for the remaining steps derives primarily from thyroid cell lines or non-thyroid experimental systems.
- 17 August 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1909257
Open AccessEndoplasmic reticulum stress in Hashimoto’s thyroiditis: a candidate amplification node linking thyroid-specific vulnerability and immune dysregulation
Hashimoto’s thyroiditis (HT) is the most prevalent autoimmune thyroid disease, characterized by lymphocytic infiltration and destruction of thyroid follicular architecture. Prior research has predominantly focused on aberrant adaptive immune activation, whereas the contribution of the thyroid follicular cell itself to this process remains incompletely elucidated. This narrative review synthesizes evidence implicating endoplasmic reticulum stress (ERS) in HT pathogenesis, stratifying the evidence by its proximity to HT pathology into three tiers: direct evidence, thyroid-cell evidence, and extrapolated evidence. Thyroid follicular cells continuously produce large quantities of structurally complex thyroglobulin, placing the ER under near-saturated folding load even under physiological conditions, thereby conferring an organ-specific vulnerability. Multiple HT-associated factors can activate the unfolded protein response (UPR), mediating thyrocyte apoptosis, suppression of functional genes, and loss of epithelial phenotype in thyroid cell models; individual UPR branches may also regulate the differentiation and function of infiltrating immune cells. Integrating the above evidence, this review proposes a testable positive-feedback perspective in which thyrocyte ERS injury and immune effector amplification may mutually reinforce one another. This perspective comprises six steps, and for each step, the strength of supporting evidence is assessed. Among these, only thyrocyte ERS activation and the macrophage IRE1α pathway have received preliminary direct evidence in HT or experimental autoimmune thyroiditis (EAT); support for the remaining steps derives primarily from thyroid cell lines or non-thyroid experimental systems.
- Open Access
- 4 December 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1689498
Autoimmune thyroid disease and human health: a systematic review of Mendelian randomization studies
We systematically summarized current Mendelian randomization (MR) evidence on the causal relationships between autoimmune thyroid disease (AITD) and a wide range of human health outcomes. Original MR studies related to AITD published up to March 1, 2025, were retrieved from PubMed and Embase. For studies investigating the same exposure–outcome associations, meta-analyses were performed to synthesize the evidence after excluding overlapping samples where applicable. The methodological quality of the included studies was assessed using the STROBE-MR checklist. A total of 123 MR publications met the inclusion criteria. MR analyses indicated that AITD significantly increased the risk of coronary atherosclerosis, deep venous thrombosis, chronic obstructive pulmonary disease, major depression, diabetic neuropathy, carpal tunnel syndrome, neuromyelitis optica spectrum disorder, diabetic retinopathy, childhood absence epilepsy, rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis, inflammatory bowel disease, crohn's disease, vitiligo, myasthenia gravis, alopecia areata, type 1 and type 2 diabetes, sarcoidosis, frozen shoulder, drug eruptions, cataract, early age-related macular degeneration, pernicious anemia, Helicobacter pylori infection, temporomandibular disorders, migraine, frailty, primary biliary cholangitis, knee osteoarthritis, gout, and osteoporosis, while decreasing the risk of lung cancer, polyneuropathies, allergic rhinitis, telomere length, and serum vitamin A levels. The included MR studies were of high methodological quality and provided robust evidence supporting the bidirectional relationships between AITD and various health outcomes. These findings emphasize the importance and necessity of preventing and managing AITD while offering new perspectives and directions for future research on its prevention and treatment. Systematic review registration: https://www.crd.york.ac.uk/prospero/ , identifier CRD42023469038.
- 4 December 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1689498
Open AccessAutoimmune thyroid disease and human health: a systematic review of Mendelian randomization studies
We systematically summarized current Mendelian randomization (MR) evidence on the causal relationships between autoimmune thyroid disease (AITD) and a wide range of human health outcomes. Original MR studies related to AITD published up to March 1, 2025, were retrieved from PubMed and Embase. For studies investigating the same exposure–outcome associations, meta-analyses were performed to synthesize the evidence after excluding overlapping samples where applicable. The methodological quality of the included studies was assessed using the STROBE-MR checklist. A total of 123 MR publications met the inclusion criteria. MR analyses indicated that AITD significantly increased the risk of coronary atherosclerosis, deep venous thrombosis, chronic obstructive pulmonary disease, major depression, diabetic neuropathy, carpal tunnel syndrome, neuromyelitis optica spectrum disorder, diabetic retinopathy, childhood absence epilepsy, rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis, inflammatory bowel disease, crohn's disease, vitiligo, myasthenia gravis, alopecia areata, type 1 and type 2 diabetes, sarcoidosis, frozen shoulder, drug eruptions, cataract, early age-related macular degeneration, pernicious anemia, Helicobacter pylori infection, temporomandibular disorders, migraine, frailty, primary biliary cholangitis, knee osteoarthritis, gout, and osteoporosis, while decreasing the risk of lung cancer, polyneuropathies, allergic rhinitis, telomere length, and serum vitamin A levels. The included MR studies were of high methodological quality and provided robust evidence supporting the bidirectional relationships between AITD and various health outcomes. These findings emphasize the importance and necessity of preventing and managing AITD while offering new perspectives and directions for future research on its prevention and treatment. Systematic review registration: https://www.crd.york.ac.uk/prospero/ , identifier CRD42023469038.
- Open Access
- 28 January 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (2) , e70263
The role of circular RNAs in autoimmune diseases: Potential diagnostic biomarkers and therapeutic targets
With the emergence of high‐quality sequencing technologies, further research on transcriptomes has become possible. Circular RNA (circRNA), a novel type of endogenous RNA molecule with a covalently closed circular structure through “back‐splicing,” is reported to be widely present in eukaryotic cells and participates mainly in regulating gene and protein expression in various ways. It is becoming a research hotspot in the non‐coding RNA field. CircRNA shows close relation to several varieties of autoimmune diseases (AIDs) in both the physiological and pathological level and could potentially be used clinically in terms of diagnosis and treatment. Here, we focus on reviewing the importance of circRNA in various AIDs, with the aim of establishing new biomarkers and providing novel insights into understanding the role and functions of circRNA in AIDs. Specific signaling pathways of how circular RNAs are regulated in AIDs will also be illustrated in this review.
- 28 January 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (2) , e70263
Open AccessThe role of circular RNAs in autoimmune diseases: Potential diagnostic biomarkers and therapeutic targets
With the emergence of high‐quality sequencing technologies, further research on transcriptomes has become possible. Circular RNA (circRNA), a novel type of endogenous RNA molecule with a covalently closed circular structure through “back‐splicing,” is reported to be widely present in eukaryotic cells and participates mainly in regulating gene and protein expression in various ways. It is becoming a research hotspot in the non‐coding RNA field. CircRNA shows close relation to several varieties of autoimmune diseases (AIDs) in both the physiological and pathological level and could potentially be used clinically in terms of diagnosis and treatment. Here, we focus on reviewing the importance of circRNA in various AIDs, with the aim of establishing new biomarkers and providing novel insights into understanding the role and functions of circRNA in AIDs. Specific signaling pathways of how circular RNAs are regulated in AIDs will also be illustrated in this review.
- Open Access
- 18 November 2024
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 18, 1470641
The clinical perspective of circular RNAs in neurodegenerative diseases: potential diagnostic tools and therapeutic targets
Neurodegenerative diseases (NDDs) mostly occur in older demographics. With the average lifespan increasing over time, NDDs are becoming one of the major adverse factors affecting human health and the quality of life. Currently, there are no specific diagnostic methods for NDDs and they are usually diagnosed based on nonspecific clinical symptoms and occasionally by biomarkers, such as β-amyloid (Aβ) for Alzheimer’s disease (AD) and a-synuclein (α-syn) for Parkinson’s disease, etc. However, it is usually too late for most treatment to startr when the aforementioned criteria become detectable. Circular RNAs (circRNAs) are a type of single-stranded, covalently closed, non-coding RNAs that lack a 5′ cap structure and 3′ terminal poly-A tail. According to recent research, circRNAs may play a crucial role for the onset and progression of some NDDs. These small RNAs may be potential diagnostic and prognostic markers and therapeutic targets for these diseases. This review will provide a comprehensive overview of the recent advancements of knowledge on the functions and the possible underlying mechanism of circRNAs in the pathogenesis and treatment of NDDs.
- 18 November 2024
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 18, 1470641
Open AccessThe clinical perspective of circular RNAs in neurodegenerative diseases: potential diagnostic tools and therapeutic targets
Neurodegenerative diseases (NDDs) mostly occur in older demographics. With the average lifespan increasing over time, NDDs are becoming one of the major adverse factors affecting human health and the quality of life. Currently, there are no specific diagnostic methods for NDDs and they are usually diagnosed based on nonspecific clinical symptoms and occasionally by biomarkers, such as β-amyloid (Aβ) for Alzheimer’s disease (AD) and a-synuclein (α-syn) for Parkinson’s disease, etc. However, it is usually too late for most treatment to startr when the aforementioned criteria become detectable. Circular RNAs (circRNAs) are a type of single-stranded, covalently closed, non-coding RNAs that lack a 5′ cap structure and 3′ terminal poly-A tail. According to recent research, circRNAs may play a crucial role for the onset and progression of some NDDs. These small RNAs may be potential diagnostic and prognostic markers and therapeutic targets for these diseases. This review will provide a comprehensive overview of the recent advancements of knowledge on the functions and the possible underlying mechanism of circRNAs in the pathogenesis and treatment of NDDs.
- Open Access
- 19 August 2024
- Published by MDPI AG in Brain Sciences
- Vol. 14 (8) , 833
Genetically Predicted Association of 91 Circulating Inflammatory Proteins with Multiple Sclerosis: A Mendelian Randomization Study
Previous studies have validated a close association between inflammatory factors and multiple sclerosis (MS), but their causal relationship is not fully profiled yet. This study used Mendelian randomization (MR) to investigate the causal effect of circulating inflammatory proteins on MS. Data from a large-scale genome-wide association study (GWAS) were analyzed using a two-sample MR method to explore the relationship between 91 circulating inflammatory proteins and MS. The inverse-variance-weighted (IVW) analysis was employed as the main method for evaluating exposures and outcomes. Furthermore, series of the methods of MR Egger, weighted median, simple mode, and weighted mode were used to fortify the final results. The results of the IVW method were corrected with Bonferroni (bon) and false discovery rate (fdr) for validating the robustness of results and ensuring the absence of heterogeneity and horizontal pleiotropy. The sensitivity analysis was also performed. The results of the forward MR analysis showed that higher levels of CCL25 were found to be associated with an increased risk of MS according to IVW results, OR: 1.085, 95% CI (1.011, 1.165), p = 2.42 × 10−2, adjusted p_adj_bon = 1, p_adj_fdr = 0.307. Similarly, higher levels of CXCL10 were found to be associated with an increased risk of MS, OR: 1.231, 95% CI (1.057, 1.433), p = 7.49 × 10−3, adjusted p_adj_bon = 0.682, p_adj_fdr = 0.227. In contrast, elevated levels of neurturin (NRTN) were associated with a decreased risk of MS, OR: 0.815, 95% CI (0.689, 0.964), p = 1.68 × 10−2, adjusted p_adj_bon = 1, p_adj_fdr = 0.307. Reverse MR analysis showed no causal relationship between MS and the identified circulating inflammatory cytokines. The effects of heterogeneity and level pleiotropy were further excluded by sensitivity analysis. This study provides new insights into the relationship between circulating inflammatory proteins and MS and brings up a new possibility of using these cytokines as potential biomarkers and therapeutic targets. The data in this study show that there are only weak associations between inflammatory molecules and MS risk, which did not survive bon and fdr correction, and the obtained p-values are quite low. Therefore, further studies on larger samples are needed.
- 19 August 2024
- Published by MDPI AG in Brain Sciences
- Vol. 14 (8) , 833
Open AccessGenetically Predicted Association of 91 Circulating Inflammatory Proteins with Multiple Sclerosis: A Mendelian Randomization Study
Previous studies have validated a close association between inflammatory factors and multiple sclerosis (MS), but their causal relationship is not fully profiled yet. This study used Mendelian randomization (MR) to investigate the causal effect of circulating inflammatory proteins on MS. Data from a large-scale genome-wide association study (GWAS) were analyzed using a two-sample MR method to explore the relationship between 91 circulating inflammatory proteins and MS. The inverse-variance-weighted (IVW) analysis was employed as the main method for evaluating exposures and outcomes. Furthermore, series of the methods of MR Egger, weighted median, simple mode, and weighted mode were used to fortify the final results. The results of the IVW method were corrected with Bonferroni (bon) and false discovery rate (fdr) for validating the robustness of results and ensuring the absence of heterogeneity and horizontal pleiotropy. The sensitivity analysis was also performed. The results of the forward MR analysis showed that higher levels of CCL25 were found to be associated with an increased risk of MS according to IVW results, OR: 1.085, 95% CI (1.011, 1.165), p = 2.42 × 10−2, adjusted p_adj_bon = 1, p_adj_fdr = 0.307. Similarly, higher levels of CXCL10 were found to be associated with an increased risk of MS, OR: 1.231, 95% CI (1.057, 1.433), p = 7.49 × 10−3, adjusted p_adj_bon = 0.682, p_adj_fdr = 0.227. In contrast, elevated levels of neurturin (NRTN) were associated with a decreased risk of MS, OR: 0.815, 95% CI (0.689, 0.964), p = 1.68 × 10−2, adjusted p_adj_bon = 1, p_adj_fdr = 0.307. Reverse MR analysis showed no causal relationship between MS and the identified circulating inflammatory cytokines. The effects of heterogeneity and level pleiotropy were further excluded by sensitivity analysis. This study provides new insights into the relationship between circulating inflammatory proteins and MS and brings up a new possibility of using these cytokines as potential biomarkers and therapeutic targets. The data in this study show that there are only weak associations between inflammatory molecules and MS risk, which did not survive bon and fdr correction, and the obtained p-values are quite low. Therefore, further studies on larger samples are needed.
- Open Access
- 14 June 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (24) , e37963
Global research landscape and emerging trends in Graves’ disease: A bibliometric analysis
Background: Graves’ disease is a prevalent thyroid disorder and is the primary cause of hyperthyroidism. Significant progress has been made in understanding the epidemiology, pathogenesis, diagnosis, treatment, and prognosis of this disease. However, bibliometric analyses on Graves’ disease are lacking. We aimed to comprehensively summarize the research, progression, and focal points of Graves’ disease through data mining and integrated analysis of the existing literature. Methods: We retrieved relevant literature on Graves’ disease from 2003 to 2023 from the Web of Science database. We performed bibliometric analysis using CiteSpace and the R package Bibliometrix. Results: We identified 10,901 publications from 132 countries, with a steady rise in the number of publications over the past 5 years. The US leads in publication volume, with the University of California System being the primary contributing institution. The journal Thyroid had the highest publication output, while the Journal of Clinical Endocrinology and Metabolism was the most frequently cited. These publications involved 2305 authors, with Antonelli Alessandro and Smith Terry being the most prolific. The most frequently cited articles were the “2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis” and the “Thyroid Association/European Group on Graves’ orbitopathy guidelines for the management of Graves’ orbitopathy.” Analysis of the bursts of cited references, keywords, and their clustering revealed that research on Graves’ disease predominantly centers on clinical management, thyroid-stimulating hormone receptors, thyroid hormones, autoimmunity and inflammation, Graves’ ophthalmopathy, thyroid nodules, and thyroid cancer. Conclusion: This is the first comprehensive bibliometric study to summarize progress and trends in Graves’ disease research. These results highlight recent research hotspots and promising directions, thereby providing a valuable reference for other scholars.
- 14 June 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (24) , e37963
Open AccessGlobal research landscape and emerging trends in Graves’ disease: A bibliometric analysis
Background: Graves’ disease is a prevalent thyroid disorder and is the primary cause of hyperthyroidism. Significant progress has been made in understanding the epidemiology, pathogenesis, diagnosis, treatment, and prognosis of this disease. However, bibliometric analyses on Graves’ disease are lacking. We aimed to comprehensively summarize the research, progression, and focal points of Graves’ disease through data mining and integrated analysis of the existing literature. Methods: We retrieved relevant literature on Graves’ disease from 2003 to 2023 from the Web of Science database. We performed bibliometric analysis using CiteSpace and the R package Bibliometrix. Results: We identified 10,901 publications from 132 countries, with a steady rise in the number of publications over the past 5 years. The US leads in publication volume, with the University of California System being the primary contributing institution. The journal Thyroid had the highest publication output, while the Journal of Clinical Endocrinology and Metabolism was the most frequently cited. These publications involved 2305 authors, with Antonelli Alessandro and Smith Terry being the most prolific. The most frequently cited articles were the “2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis” and the “Thyroid Association/European Group on Graves’ orbitopathy guidelines for the management of Graves’ orbitopathy.” Analysis of the bursts of cited references, keywords, and their clustering revealed that research on Graves’ disease predominantly centers on clinical management, thyroid-stimulating hormone receptors, thyroid hormones, autoimmunity and inflammation, Graves’ ophthalmopathy, thyroid nodules, and thyroid cancer. Conclusion: This is the first comprehensive bibliometric study to summarize progress and trends in Graves’ disease research. These results highlight recent research hotspots and promising directions, thereby providing a valuable reference for other scholars.
- Open Access
- 30 April 2024
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1338325
Bibliometric and visualization analyses of cancer-related fatigue research published worldwide from 2001 to 2023
Objective: Cancer seriously endangers human health and represents a global public health issue. Cancer-related fatigue (CRF) is a distressing and persistent sense of exhaustion caused by cancer or cancer treatment, widely prevalent among cancer patients. This study aims to summarize emerging trends and provide directions for future research of CRF through bibliometric and visualization analyses.Methods: A systematic search in the Web of Science Core Collection database from 2001-01-01 to 2023-05-18 were conducted. Only reviews and articles written in English were considered. CiteSpace and the R were used for bibliometric and visualization analyses.Results: The analysis revealed that 2,566 studies on CRF have been published by 1,041 institutions in 70 countries so far. The number of articles published and cited annually have been steadily increasing. Eduardo Bruera published the most articles, and Julienne E Bower is the most co-cited author. The University of Texas System is the leading institution in cancer-related fatigue research. The United States and China have the largest number of publications. Supportive Care in Cancer published the most articles, and Journal of Clinical Oncology is the most co-cited journal. “Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-analysis”, authored by Mustian KM et al. and published in JAMA Oncology was the most co-cited document. Keyword analysis indicated that research focus had shifted from “epoetin alpha” and “anemia” to “risk factors”, “systematic review”, “acupuncture”, “anxiety”, “traditional Chinese medicine” and “guidelines”.Conclusion: In conclusion, this analysis provides comprehensive research trends and knowledge network maps of CRF. Clinical physicians should concurrently focus on the anemia, insomnia, anxiety, and depression status of patients when assessing or managing CRF. Improvements in related risk factors also contribute to alleviating fatigue. Furthermore, it is essential to pay attention to authoritative CRF guidelines. Acupuncture and traditional Chinese medicine also have therapeutic potential, which merits further investigation. Researchers should draw attention to the crucial roles of inflammation, hypoxia, and mitochondrial dysfunction, which could be the frontiers.
- 30 April 2024
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1338325
Open AccessBibliometric and visualization analyses of cancer-related fatigue research published worldwide from 2001 to 2023
Objective: Cancer seriously endangers human health and represents a global public health issue. Cancer-related fatigue (CRF) is a distressing and persistent sense of exhaustion caused by cancer or cancer treatment, widely prevalent among cancer patients. This study aims to summarize emerging trends and provide directions for future research of CRF through bibliometric and visualization analyses.Methods: A systematic search in the Web of Science Core Collection database from 2001-01-01 to 2023-05-18 were conducted. Only reviews and articles written in English were considered. CiteSpace and the R were used for bibliometric and visualization analyses.Results: The analysis revealed that 2,566 studies on CRF have been published by 1,041 institutions in 70 countries so far. The number of articles published and cited annually have been steadily increasing. Eduardo Bruera published the most articles, and Julienne E Bower is the most co-cited author. The University of Texas System is the leading institution in cancer-related fatigue research. The United States and China have the largest number of publications. Supportive Care in Cancer published the most articles, and Journal of Clinical Oncology is the most co-cited journal. “Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-analysis”, authored by Mustian KM et al. and published in JAMA Oncology was the most co-cited document. Keyword analysis indicated that research focus had shifted from “epoetin alpha” and “anemia” to “risk factors”, “systematic review”, “acupuncture”, “anxiety”, “traditional Chinese medicine” and “guidelines”.Conclusion: In conclusion, this analysis provides comprehensive research trends and knowledge network maps of CRF. Clinical physicians should concurrently focus on the anemia, insomnia, anxiety, and depression status of patients when assessing or managing CRF. Improvements in related risk factors also contribute to alleviating fatigue. Furthermore, it is essential to pay attention to authoritative CRF guidelines. Acupuncture and traditional Chinese medicine also have therapeutic potential, which merits further investigation. Researchers should draw attention to the crucial roles of inflammation, hypoxia, and mitochondrial dysfunction, which could be the frontiers.
- Open Access
- 3 October 2023
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1259520
Borderline personality disorder and thyroid diseases: a Mendelian randomization study
Background: Previous studies have shown that there is a correlation between diseases of the thyroid gland and mental illnesses; however, any causal relationship between them remains unclear. This study aimed to evaluate the causal relationship between borderline personality disorder and four thyroid diseases.Methods: The causal relationship was inferred using double-sample Mendelian randomization analysis of appropriate instrumental variables from genome-wide association studies. We calculated the estimated value of the effect using various statistical methods.Results: Borderline personality disorder was a risk factor for non-toxic single thyroid nodules with each increase in standard deviation increasing the risk of a non-toxic single thyroid nodule by 1.13 times (odds ratio = 1.131; 95% confidence interval, 1.006-1.270; P=0.039). There was no evidence of a correlation between borderline personality disorder and hyperthyroidism/thyrotoxicosis, hypothyroidism, and autoimmune thyroiditis.Conclusion: This study showed that there is a positive causal correlation between borderline personality disorder and non-toxic single thyroid nodules but not with other thyroid diseases. This means that thyroid status should be monitored in patients with borderline personality disorder. However, the possibility of a causal relationship between other mental illnesses and thyroid diseases requires further research.
- 3 October 2023
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1259520
Open AccessBorderline personality disorder and thyroid diseases: a Mendelian randomization study
Background: Previous studies have shown that there is a correlation between diseases of the thyroid gland and mental illnesses; however, any causal relationship between them remains unclear. This study aimed to evaluate the causal relationship between borderline personality disorder and four thyroid diseases.Methods: The causal relationship was inferred using double-sample Mendelian randomization analysis of appropriate instrumental variables from genome-wide association studies. We calculated the estimated value of the effect using various statistical methods.Results: Borderline personality disorder was a risk factor for non-toxic single thyroid nodules with each increase in standard deviation increasing the risk of a non-toxic single thyroid nodule by 1.13 times (odds ratio = 1.131; 95% confidence interval, 1.006-1.270; P=0.039). There was no evidence of a correlation between borderline personality disorder and hyperthyroidism/thyrotoxicosis, hypothyroidism, and autoimmune thyroiditis.Conclusion: This study showed that there is a positive causal correlation between borderline personality disorder and non-toxic single thyroid nodules but not with other thyroid diseases. This means that thyroid status should be monitored in patients with borderline personality disorder. However, the possibility of a causal relationship between other mental illnesses and thyroid diseases requires further research.
- Open Access
- 23 April 2019
- Published by Wiley in BioMed Research International
- Vol. 2019, 1-7
Shenqi Fuzheng Injection (SFI) Enhances IFN-α Inhibitory Effect on Hepatocellular Carcinoma Cells by Reducing VEGF Expression: Validation by Gene Silencing Technique
Shenqi Fuzheng Injection (SFI) is a traditional Chinese medicine injection with anticancer properties and is mainly composed of ginseng and astragalus. Its efficacy has been confirmed in clinical trials, but the mechanism remains unclear. We investigated the effect of SFI on vascular endothelial growth factor (VEGF) gene expression in hepatocellular carcinoma (HCC) cells and identified its possible mechanism of synergistic effects when combined with the chemotherapeutic drug interferon (IFN-) α. An MTT assay was used to measure the inhibition effects of low-dose IFN-α (6000 IU) with or without SFI (0.5 g/L) on the HCC cell line MHCC97. VEGF-silenced MHCC97L-mir200 cell lines were prepared using lentiviral vectors and evaluated by real-time PCR to determine the inhibition effect. We examined MHCC97L-mir200 and MHCC97L cells by MTT assay, using IFN-α alone or in combination with SFI. The inhibition ratio of IFN-α (6000 IU) was -29.5%, while that for IFN-α (6000 IU) + SFI (0.5 g/L) was 17.0%, which was significantly higher than that for the IFN-α group (P < 0.01). The VEGF gene was silenced successfully in MHCC97-L cells. After interference of VEGF, the inhibition by SFI and IFN-α in MHCC97L-mir200 did not differ from that in MHCC97-L cells (P > 0.05). SFI can reduce the expression of VEGF in HCC, which can increase the efficacy of IFN-α, providing a theoretical basis for clinical application.
- 23 April 2019
- Published by Wiley in BioMed Research International
- Vol. 2019, 1-7
Open AccessShenqi Fuzheng Injection (SFI) Enhances IFN-α Inhibitory Effect on Hepatocellular Carcinoma Cells by Reducing VEGF Expression: Validation by Gene Silencing Technique
Shenqi Fuzheng Injection (SFI) is a traditional Chinese medicine injection with anticancer properties and is mainly composed of ginseng and astragalus. Its efficacy has been confirmed in clinical trials, but the mechanism remains unclear. We investigated the effect of SFI on vascular endothelial growth factor (VEGF) gene expression in hepatocellular carcinoma (HCC) cells and identified its possible mechanism of synergistic effects when combined with the chemotherapeutic drug interferon (IFN-) α. An MTT assay was used to measure the inhibition effects of low-dose IFN-α (6000 IU) with or without SFI (0.5 g/L) on the HCC cell line MHCC97. VEGF-silenced MHCC97L-mir200 cell lines were prepared using lentiviral vectors and evaluated by real-time PCR to determine the inhibition effect. We examined MHCC97L-mir200 and MHCC97L cells by MTT assay, using IFN-α alone or in combination with SFI. The inhibition ratio of IFN-α (6000 IU) was -29.5%, while that for IFN-α (6000 IU) + SFI (0.5 g/L) was 17.0%, which was significantly higher than that for the IFN-α group (P < 0.01). The VEGF gene was silenced successfully in MHCC97-L cells. After interference of VEGF, the inhibition by SFI and IFN-α in MHCC97L-mir200 did not differ from that in MHCC97-L cells (P > 0.05). SFI can reduce the expression of VEGF in HCC, which can increase the efficacy of IFN-α, providing a theoretical basis for clinical application.